A big, encouraging study landed this week. Let’s read it like scientists, not headline writers.
If you spent any time online this week, you probably saw some version of this headline: “Estrogen slashes Alzheimer’s risk by 35%.” And if you’re a woman in your 40s or 50s trying to make a hormone decision, a headline like that can hit like a lightning bolt. Hope and pressure, all at once.
So let’s do what we always do here. Slow down and look at what the study actually found, what it didn’t, and what it changes for you (if anything). Real science, real nuance, zero judgment.
What the study found
Published August 12 in the journal Neurology, researchers combined two large datasets. That included 258 women whose brains were examined at autopsy, plus thousands more tracked clinically over time. They compared women who had used estrogen-only hormone therapy to women who used none.
The women who’d used estrogen-only therapy had:
- About 35% lower odds of having Alzheimer’s-defining changes in their brain tissue (the amyloid plaques and tangles that pathologists look for)
- About 39% lower odds of having been diagnosed with dementia during their lives
- Better scores on memory and cognitive function over time
What makes this one interesting is that it didn’t just rely on diagnoses or memory tests. It looked at actual brain tissue. That’s a rare and pretty compelling window.
Now the part the headlines skipped
Stay with me here, because this is the difference between being informed and being sold to.
This was an observational study, which means it can’t prove cause and effect. The researchers said so themselves, plainly: the findings “do not address causality.” What they found is an association. Estrogen use and lower Alzheimer’s pathology showed up together in this data. That is not the same as estrogen causing the lower risk.
Why does that matter so much? Because women who used hormone therapy in these decades were often, on average, healthier and more engaged with their medical care to begin with, and those things affect brain health on their own. Researchers try to adjust for it, but observational data can never fully untangle it. (You’ll hear this called the “healthy-user effect.”)
A few more pieces of fine print worth knowing:
- It was estrogen only. These findings don’t automatically apply to estrogen-plus-progestogen therapy, which is what’s usually prescribed for women who still have a uterus. Estrogen-only therapy is generally used by women who’ve had a hysterectomy.
- It was oral estrogen, so the results don’t necessarily transfer to patches, gels, or other forms.
- These were older women. The average participant was in her 70s or beyond, and hormone use was self-reported, which leaves room for memory and record-keeping gaps.
- The authors themselves called the effect “small but significant.” That’s meaningful for science, but it’s not a miracle.
None of this makes the study unimportant. It makes it one strong brick in a growing wall of evidence, not the whole house.
Want to create a custom longevity health plan?
You’re in the right place.
I can help you with a functional approach to midlife women’s health including hormone balance, gut health, autoimmune issues, bone health, heart health and more!
What’s different in 2026?
For twenty years, a lot of us were steered away from hormone therapy entirely, ever since the early-2000s Women’s Health Initiative headlines scared a whole generation of women (and a whole generation of doctors). Much of that fear, we now understand, came from studies done in older women, years past menopause, using specific formulations. The nuance got lost, and women paid for it in sleepless nights, brain fog, and suffering that got waved off as “just aging.” Studies like this one are part of a bigger re-examination. That includes growing interest in the “timing hypothesis,” the idea that when a woman starts hormone therapy (closer to menopause versus many years later) may shape the risks and benefits, including for the brain. It’s still a hypothesis being tested, not a settled rule. But it’s a big reason this conversation is finally opening back up.So what do you actually do with this?
Not this: call your doctor Monday demanding estrogen to prevent dementia. That’s not what this study supports, and I’m not going to pretend otherwise. Here’s what it does support. Use it as fuel for a better, more honest conversation about your hormones and your health. That looks like:- Get clear on your own picture first. Your symptoms, your personal and family history (including breast cancer, clots, and heart disease), whether you still have a uterus, and how far you are from your final period all shape whether hormone therapy makes sense for you.
- Ask specific questions. Something like, “Given my history and where I am in menopause, am I a candidate for hormone therapy? What type, what route, and what are the real risks and benefits in my case?” A good provider will welcome that.
- Don’t let anyone hand you a one-size protocol, in either direction. “Hormones are dangerous, absolutely not” is as lazy as “everyone should be on hormones.” You deserve a decision built around you.
- Remember hormones are one lever, not the only one. Sleep, strength training, protein, and blood sugar are doing enormous work for your brain right now, no prescription required.
Frequently Asked Questions
Does estrogen therapy prevent Alzheimer’s disease?
Not that we can say. The 2026 Neurology study found that women who used estrogen-only therapy had lower odds of Alzheimer’s changes, but it was observational and cannot prove estrogen was the cause. It’s an encouraging association, not proof of prevention.
What did the 2026 estrogen and Alzheimer’s study actually find?
Women who used estrogen-only hormone therapy had roughly 35% lower odds of Alzheimer’s-related changes in brain tissue and about 39% lower odds of a dementia diagnosis, along with better memory scores. The authors described the effect as “small but significant” and said it does not establish causality.
Is estrogen-only therapy the same as the HRT most women take?
Not always. Estrogen-only therapy is generally used by women who’ve had a hysterectomy. Women who still have a uterus are usually prescribed estrogen plus a progestogen to protect the uterine lining, and this study’s findings don’t automatically apply to that combination.
Who is a candidate for menopausal hormone therapy?
It depends on your symptoms, how far you are from your final period, and your personal and family history, including breast cancer, blood clots, and heart disease. There’s no universal yes or no. The right answer comes from an individualized conversation with a knowledgeable provider.
What is the “timing hypothesis”?
It’s the idea that starting hormone therapy closer to menopause, rather than many years later, may change the balance of risks and benefits, possibly including effects on the brain. It’s an active area of research, not a settled rule.
Should I start hormone therapy because of this study?
No single study should drive that decision, and this one can’t prove cause and effect. Use it as a reason to have a thorough, individualized conversation about whether hormone therapy fits your symptoms, history, and goals.
References
Bruno, J., Shaw, J., & Hosseini, H. (2026). Association between menopausal hormone therapy and Alzheimer disease neuropathology. Neurology, 107(5), e218413. https://doi.org/10.1212/WNL.0000000000218413
Stanford Medicine. (2026, August 12). Study ties estrogen-based menopausal hormone therapy to lower Alzheimer’s risk. https://med.stanford.edu/news/all-news/2026/08/study-ties-estrogen-based-menopausal-hormone-therapy-to-lower-al.html
Rossouw, J. E., Anderson, G. L., Prentice, R. L., LaCroix, A. Z., Kooperberg, C., Stefanick, M. L., … Writing Group for the Women’s Health Initiative Investigators. (2002). Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women’s Health Initiative randomized controlled trial. JAMA, 288(3), 321–333. https://doi.org/10.1001/jama.288.3.321
Dr. Anna Garrett is a menopause expert and Doctor of Pharmacy. She helps women who are struggling with symptoms of perimenopause and menopause find natural hormone balancing solutions so they can rock their mojo through midlife and beyond. Dr. Anna is the author of Perimenopause: The Savvy Sister’s Guide to Hormone Harmony. Order your copy at www.perimenopausebook.com.
Dr. Anna is available for 1-1 consultations. Find out more at www.drannagarrett.com/lets-
